An interventional study of Short linguistic content and Long linguistic content in Hearing Impaired Children, sponsored by University of Illinois Chicago. Not yet recruiting. Open to participants aged 5 Years to 7 Years. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by University of Illinois Chicago · Not applicable, Interventional, and Basic science
The goal of this basic experimental study involving humans (BESH) clinical trial is to examine how stimulus length affects grammar learning in children who are deaf or hard-of-hearing and who primarily use spoken language. The main question it aims to answer is: do short or long stimuli better support grammar learning in this population? Participants will complete an artificial grammar learning task to see which condition (short vs. long stimuli) results in better grammar learning.
796 studies on the registry are indexed under Hearing Loss; 193 are open to participants now.
This study's planned enrollment of 30 is below the median of 44 across 561 interventional studies indexed under Hearing Loss.
Browse Hearing Loss studies →University of Illinois Chicago is the lead sponsor of 20 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Children will complete an artificial grammar learning task. They will passively listen to two grammar-like auditory sequences in one of two experimental conditions that differ in syllable length. In the short condition, the sequences will contain 1-syllable stimuli. In the long condition, the sequences will contain 4-syllable stimuli.
Behavioral: Short linguistic content · Behavioral: Long linguistic content
Grammar-like auditory stimuli will comprise short linguistic content.
Grammar-like auditory stimuli will comprise long linguistic content.
Accuracy on third grammaticality judgment test
Participants will be presented with novel, grammar-like auditory stimuli. They will decide whether each stimulus matches or does not match the artificial language that they were previously presented with.
Time frame: End of day 2 of the artificial grammar learning task
Accuracy on first grammaticality judgment test
Participants will be presented with novel, grammar-like auditory stimuli. They will decide whether each stimulus matches or does not match the artificial language that they were previously presented with.
Time frame: Middle of day 1 of the artificial grammar learning task
Accuracy on the second grammaticality judgment task
Participants will be presented with novel, grammar-like auditory stimuli. They will decide whether each stimulus matches or does not match the artificial language they were presented with previously.
Time frame: Start of day 2 of the artificial grammar learning task
No study locations are listed for this record.
Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.
Of 196 non-industry interventional studies with no phase under Hearing Loss, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 59. This study's planned 7 months is below that.
Counting every sponsor, half of 321 studies reached it within 19 months; a quarter within 5 and three quarters within 42.
Start moved once since we started tracking on Sep 25, 2026: Sep 2026 → Nov 2026, on Nov 5, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Illinois Chicago